NO induces apoptosis and inhibits autophagy in human hepatoma cells by disrupting the Beclin 1/VPS34 association and increasing the Bcl-2/Beclin 1 interaction, which may provide a novel strategy for the treatment of hepatocellular carcinoma (HCC) [74]. This evidence concerns the gene BCL2 and hepatocellular carcinoma.